The National Psoriasis Foundation (NPF) Medical Board is made up of experts in the field of psoriatic disease. The Medical Board provides clinical direction, treatment guidance, and provider education oversight to the organization and its Executive leaders.
The Medical Board:
CHAIR
Blauvelt Consulting, LLC
Annapolis, Maryland
VICE CHAIR
Washington Dermatology Center
Rockville, Maryland
CHAIR EMERITUS
UCLA School of Medicine
Los Angeles, California
Synergy Dermatology
UCSF Dermatology
San Francisco, California
Cleveland Clinic
Cleveland, Ohio
Yale University School of Medicine
New Haven, Connecticut
Weill Cornell
New York, New York
Innovative Dermatology
Plano, Texas
Glick Skin Institute
Margate, Florida
Icahn School of Medicine at Mount Sinai
New York, New York
Oregon Medical Research Center
Portland, Oregon
Temple University School of Medicine
Philadelphia, Pennsylvania
Buffalo Medical Group
Williamsville, New York
Mount Sinai
New York, New York
Howard University
Washington, DC
Kindred Hair & Skin Center
Marriottsville, Maryland
CHAIR EMERITUS
University of California, San Francisco Medical Center
San Francisco, California
CHAIR EMERITUS
University of Utah School of Medicine
Salt Lake City, Utah
CHAIR EMERITUS
Icahn School of Medicine at Mount Sinai
New York, New York
Illinois Dermatology Institute, LLC
Chicago, Illinois
Bellevue Dermatology
Bellevue, Washington
UT Southwestern Medical Center
Dallas, Texas
Southern Skies Dermatology & Surgery
Oxford, Alabama
NYU Grossman School of Medicine
New York, New York
72nd Street Medical Associates
New York, New York
Yale University
New Haven, Connecticut
Central Connecticut Dermatology
Cromwell, Connecticut
Arthritis and Rheumatism Associates
Rockville, Maryland
Southern California Dermatology
Santa Ana, California
CHAIR EMERITUS
Eastern Virginia Medical School
Norfolk, Virginia
University of Colorado School of Medicine
Aurora, Colorado
Medical University of South Carolina
Charleston, South Carolina
University of Toronto
Toronto, Ontario, Canada
Last updated July, 2024
The Scientific Advisory Committee is responsible for identifying and reaching consensus upon the most promising active areas of research in the fields of psoriasis, psoriatic arthritis, and related comorbidities. The Committee will offer predictions for the future path of research in these fields and offer suggestions for how NPF can build programs to align with this path. While recognizing the fluidity of scientific discovery, the committee will advise NPF and its stakeholders on emerging data and key stakeholders in relevant areas of science and clinical research.
CHAIR
Grossman School of Medicine
New York University
New York, New York
Women’s College Research Institute
University of Toronto
Toronto, Canada
Janssen Biotech Inc.
Philadelphia, Pennsylvania
Grossman School of Medicine
New York University
New York, New York
University of Pennsylvania
Philadelphia, Pennsylvania
Icahn School of Medicine at Mount Sinai
New York, New York
Grossman School of Medicine
New York University
New York, New York
Oregon Medical Research Center
Portland, Oregon
University of California, Davis
Davis, California
University of California, San Francisco
School of Medicine
San Francisco, California
University of California, Davis
Sacramento, California
The George Washington University School of Medicine
Washington, DC
UT Southwestern Medical Center
Dallas, Texas
University of Michigan
Michigan Medicine
Ann Arbor, Michigan
University of Pennsylvania
Philadelphia, Pennsylvania
Brigham and Women’s Hospital
Harvard Medical School
Boston, Massachusetts
University of Rochester Medical Center
Rochester, New York
UCB, Inc.
Atlanta, Georgia
Vanderbilt University
Nashville, Tennessee
AbbVie, Inc.
Libertyville, Illinois
University of Miami
Coral Gables, Florida
Last updated December, 2024
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.